Internal Medicine, Gastroenterology · Cookeville, TN
NPI
1063473569
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
438 N Whitney Ave
Cookeville, TN, 38501
Phone (931) 783-2616
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
1,216 services
Medicare patients, 2024
566
Average age 72
Drug cost, 2024
$615K
1,873 prescriptions
Company payments, 2025
$94.51
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James C Ezi-Ashi was code 43239 (upper gi endoscopy), 194 times for 185 patients. In total James C Ezi-Ashi billed 1,216 services in 41 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 43239 Upper GI Endoscopy | Facility | 194 | 185 | $65.35 | $13K |
| 99213 Office E&M - Established | Office | 186 | 139 | $55.55 | $10K |
| 45385 Colonoscopy - Lesion Removal | Facility | 140 | 138 | $185.01 | $26K |
| 99214 Office E&M - Established | Office | 93 | 70 | $87.81 | $8,166 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 74 | 74 | $150.82 | $11K |
| 43450 Digestive/Gastrointestinal | Facility | 56 | 56 | $27.53 | $1,542 |
| 99222 Hospital E&M - Initial | Facility | 56 | 55 | $94.68 | $5,302 |
| 45378 Lower GI Endoscopy - Other | Facility | 43 | 42 | $121.07 | $5,206 |
| 99203 Office E&M - New | Office | 40 | 40 | $69.99 | $2,800 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 37 | 32 | $11.52 | $426 |
| 45380 Lower GI Endoscopy - Other | Facility | 30 | 30 | $79.66 | $2,390 |
| 99204 Office E&M - New | Office | 29 | 29 | $107.90 | $3,129 |
| 36415 Venipuncture Blood Collection | Office | 28 | 25 | $8.65 | $242 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 26 | 26 | $159.02 | $4,134 |
| 45381 Lower GI Endoscopy - Other | Facility | 22 | 22 | $30.07 | $662 |
By year: 2022 $97K for 1,099 services; 2023 $117K for 1,205 services; 2024 $113K for 1,216 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 28 | 25 | $8.65 | $242 |
Medicare prescription drug claims, 2024
In 2024, the drug James C Ezi-Ashi prescribed most often to Medicare patients was Pantoprazole Sodium, with 350 prescriptions and refills. In total James C Ezi-Ashi wrote 1,873 Medicare prescriptions that cost $615K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 350 | 729 | 151 | $7,123 |
| Cholestyramine Cholestyramine (With Sugar) | 345 | 535 | 193 | $22K |
| Sucralfate Generic | 251 | 304 | 149 | $8,756 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 99 | 99 | 98 | $16K |
| Omeprazole Generic | 91 | 157 | 41 | $1,119 |
| Xifaxan Rifaximin | 58 | 58 | Under 11 | $179K |
| Linzess Linaclotide | 53 | 75 | 13 | $41K |
| Mesalamine Generic | 47 | 72 | 11 | $20K |
| Colestipol Hcl Generic | 44 | 60 | 18 | $3,930 |
| Dexlansoprazole Dr Dexlansoprazole | 41 | 47 | Under 11 | $6,217 |
| Lubiprostone Generic | 38 | 48 | Under 11 | $4,643 |
| Motegrity Prucalopride Succinate | 32 | 34 | Under 11 | $18K |
| Ursodiol Generic | 32 | 70 | Under 11 | $5,188 |
| Colesevelam Hcl Generic | 31 | 45 | 16 | $6,804 |
| Entecavir Generic | 30 | 44 | Under 11 | $19K |
Brand drugs: 424 claims; generic drugs: 1,449 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James C Ezi-Ashi $94.51 ($94.51 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novo Nordisk Inc with $24.35.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.